Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB. Drago V, et al. Among authors: klafki hw. J Alzheimers Dis. 2011;26 Suppl 3:159-99. doi: 10.3233/JAD-2011-0043. J Alzheimers Dis. 2011. PMID: 21971460 Review.
Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia.
Spitzer P, Schieb H, Kamrowski-Kruck H, Otto M, Chiasserini D, Parnetti L, Herukka SK, Schuchhardt J, Wiltfang J, Klafki HW. Spitzer P, et al. Among authors: klafki hw. Int J Alzheimers Dis. 2011;2011:739847. doi: 10.4061/2011/739847. Epub 2011 Nov 24. Int J Alzheimers Dis. 2011. PMID: 22145083 Free PMC article.
Distinct fractional Abeta release patterns in human mononuclear phagocytes.
Maler JM, Spitzer P, Klafki HW, Esselmann H, Lewczuk P, Kornhuber J, Herrmann M, Wiltfang J. Maler JM, et al. Among authors: klafki hw. J Neuroimmunol. 2009 Jan 3;206(1-2):1-4. doi: 10.1016/j.jneuroim.2008.08.010. Epub 2008 Sep 27. J Neuroimmunol. 2009. PMID: 18824266
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form.
Klafki HW, Lewczuk P, Kamrowski-Kruck H, Maler JM, Müller K, Peters O, Heuser I, Jessen F, Popp J, Frölich L, Wolf S, Prinz B, Luckhaus C, Schröder J, Pantel J, Gertz HJ, Kölsch H, Müller BW, Esselmann H, Bibl M, Kornhuber J, Wiltfang J. Klafki HW, et al. J Alzheimers Dis. 2009;18(3):613-22. doi: 10.3233/JAD-2009-1167. J Alzheimers Dis. 2009. PMID: 19625747
Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.
Welge V, Fiege O, Lewczuk P, Mollenhauer B, Esselmann H, Klafki HW, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J, Bibl M. Welge V, et al. Among authors: klafki hw. J Neural Transm (Vienna). 2009 Feb;116(2):203-12. doi: 10.1007/s00702-008-0177-6. Epub 2009 Jan 14. J Neural Transm (Vienna). 2009. PMID: 19142572
56 results